Results 121 to 130 of about 10,116 (213)

Reply to Ståhl et al. Comment on "Honndorf et al. Comparative Analytics and Pharmacodynamics of the Complex Protein-Free Botulinum Toxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA and RelabotulinumtoxinA. <i>Toxins</i> 2026, <i>18</i>, 142". [PDF]

Toxins (Basel)
Honndorf S, Kühbach K, Eisele KH, Shokurova A, Buch P, Jatzke C, Taylor HV, Fink K.   +7 more
europepmc   +1 more source

Early Onset of AbobotulinumtoxinA Effects in Post-Stroke Upper Limb Spasticity: A Prospective Observational Pilot Study. [PDF]

Toxins (Basel)
Marvulli R, Caforio Montesardo S, Moccia C, Megna M, Ranieri M.   +4 more
europepmc   +1 more source

Active Function Improvement with Repeated Injections of Botulinum Toxin A in Upper Limb Spasticity: A Longitudinal Analysis from the ULIS-III Study. [PDF]

Toxins (Basel)
Ashford SA, Weatherall M, Fheodoroff K, Jacinto J, Siegert RJ, Hannes C, Turner-Stokes L.   +6 more
europepmc   +1 more source

Pain-Specific Benefits of Higher-Dose Neubotulinum Toxin Type A in Cervical Dystonia: A Multicenter Randomized Double-Blind Crossover Trial. [PDF]

Toxins (Basel)
Arayawichanont A, Kongsaengdao S.
europepmc   +1 more source

Goal Attainment and Outcome Evaluation for Upper and Lower Limb Spasticity: A Real-Life Cohort Analysis in a Community-Based Outreach Service. [PDF]

Toxins (Basel)
Steed A, Williams H, Alfonso J, Hancock D, Ashford SA.   +4 more
europepmc   +1 more source

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A. [PDF]

Toxins (Basel)
Nam JS, Yoon D, Kim Y, Kim SY, Kim JY, Cha Y, Seok J, Kim BJ.   +7 more
europepmc   +1 more source

Early Treatment of Post-Stroke Spasticity with Botulinum Toxin Type A: Myth or Reality? [PDF]

Toxins (Basel)
Picelli A, Di Censo R, Smania N, Varalta V, Filippetti M.   +4 more
europepmc   +1 more source

Botulinum Toxin for Temporomandibular Disorder: Current Evidence, Clinical Applications, and Future Perspectives. [PDF]

Toxins (Basel)
Ferrillo M, Curci C, Calafiore D, Lippi L, Yumuşakhuylu Y, Vecchio M, Quinzi V, Rosa A, Invernizzi M, de Sire A.   +9 more
europepmc   +1 more source

Treatment of hypertrophic scars using fractional CO2 laser alone in comparison with adding botulinium toxin either intalesional injection or assisted drug delivery. [PDF]

Lasers Med Sci
Fahim A, Saied E, El-Mesidy MS.
europepmc   +1 more source

Masseter Muscle in Somatosensory Tinnitus and Potential Therapeutic Role for Botulinum Toxin Type A: A Scoping Review. [PDF]

Toxins (Basel)
Gardellin J, D'Angelo M, Spadotto L, Checchin G, Gaetti G, Gambolò L, Stirparo G, Merli N.   +7 more
europepmc   +1 more source